Peptide comparison tool
Compare 2 peptides side by side: FDA status, proof, safety, and sports rules.
By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts
Turn on JavaScript to pick any two peptides. The popular comparisons below work without it.
Both: Not an FDA-approved medicine. This alone does not tell you if it works.
Only 3 tiny reports in people (30 people in all), with no fake-shot group to compare.
No published study of TB-500 itself in people. Small trials tested the full natural protein instead.
About 30 people, for a short time. Long-term risks are unknown.
No published safety data for TB-500 shots in people.
healing injuries and pain
muscle and injury recovery
Yes. WADA names BPC-157 by name as banned at all times, in and out of competition (2026 list, section S0: drugs not approved for people).
Yes. WADA bans TB-500 at all times, in and out of competition.
Read next: BPC-157 vs TB-500: What Is the Difference? · BPC-157 vs KPV: What Is the Difference? · Are collagen peptides the same as peptides?
FDA status, proof, and safety are rated separately. Little safety data means risks are unknown, not that a peptide fails. "Not FDA approved" is not the same as illegal. We never share doses or link research-peptide sellers.
Popular comparisons
BPC-157 vs TB-500: which is better?
No one knows. Neither is FDA approved, and no study has compared them. BPC-157 has 3 tiny reports in people. We found no published study of TB-500 itself in people.
Both are banned in sports by WADA. See our full BPC-157 vs TB-500 guide.
Semaglutide vs tirzepatide: which works better for weight loss?
In a 72-week head-to-head trial of 751 adults with obesity, people on tirzepatide (Zepbound) lost about 20.2% of their weight on average. People on semaglutide (Wegovy) lost about 13.7%.
Both are FDA approved. Stomach side effects were the most common with both.
Retatrutide vs tirzepatide: what is the difference?
Tirzepatide (Zepbound, Mounjaro) is FDA approved. It works on 2 hormone switches: GLP-1 and GIP.
Retatrutide works on 3: GLP-1, GIP, and glucagon. It is still in testing and is not approved. People online call it "GLP-3."
Numbers from separate trials are not a fair comparison. Only a head-to-head trial can say which works better.
Ipamorelin vs tesamorelin: what is the difference?
Tesamorelin (Egrifta) is FDA approved for one thing: reducing deep belly fat in adults with HIV. A big trial with 412 people met its goal.
Ipamorelin is not approved. No study in people has tested it for muscle, sleep, or anti-aging.
WADA bans both in sports.
Why does this tool show 3 separate ratings?
FDA status is about the law. Proof is about the science. Safety data is about how much we know about harms. They do not always match.
A peptide can be approved for one use and unproven for another. A peptide with little safety data has unknown risks. That does not mean it does not work.
"Not FDA approved" does not by itself mean illegal to have. Our legal guide explains the rules.
Is there a peptide price comparison tool?
Not here. People search for "peptide price comparison," but we never list research-peptide prices, doses, or sellers. We do not recommend vendors.
For FDA-approved medicines, ask your pharmacist or the drug maker’s official site about cost.
Peptide comparison chart: popular pairs
BPC-157 vs TB-500
GLP-1: Wegovy / Ozempic (semaglutide) vs GLP-1: Zepbound / Mounjaro (tirzepatide)
GLP-1: Wegovy / Ozempic (semaglutide) page · GLP-1: Zepbound / Mounjaro (tirzepatide) page
GLP-1: Retatrutide vs GLP-1: Zepbound / Mounjaro (tirzepatide)
GLP-1: Retatrutide page · GLP-1: Zepbound / Mounjaro (tirzepatide) page
BPC-157 vs KPV
Ipamorelin vs Egrifta (tesamorelin)
GLP-1: Retatrutide vs GLP-1: Wegovy / Ozempic (semaglutide)
GLP-1: Retatrutide page · GLP-1: Wegovy / Ozempic (semaglutide) page
BPC-157 vs GHK-Cu
Ipamorelin vs Sermorelin
Ipamorelin vs CJC-1295
TB-500 vs KPV
GLP-1: Survodutide vs GLP-1: Retatrutide
GLP-1: Mazdutide vs GLP-1: Retatrutide
BPC-157 vs CJC-1295
Epitalon vs DSIP (emideltide)
GLP-1: Saxenda / Victoza (liraglutide) vs GLP-1: Wegovy / Ozempic (semaglutide)
GLP-1: Saxenda / Victoza (liraglutide) page · GLP-1: Wegovy / Ozempic (semaglutide) page
Egrifta (tesamorelin) vs Sermorelin
FAQ
Can I compare any two peptides?
Yes. Pick any two of the 50 peptides on our A-Z list, one in each box.
Where do the ratings come from?
From our peptide pages. Each rating is based on FDA pages, FDA drug labels, PubMed, or ClinicalTrials.gov, checked in October 2026.
Can I share a comparison?
Yes. The page address changes to match your picks, like #bpc-157-vs-tb-500. Copy and send it.
Does "banned in sports" mean it shows up on a work drug test?
No. Sports tests and work tests look for different things. Use our drug test checker to see both.
Why is a peptide I searched for missing?
We only list peptides we have fact-checked. Use our FDA status checker or contact us to suggest one.
Related pages
- Is my peptide FDA approved?Tool
- Do peptides show up on a drug test?Tool
- Is my peptide source legit?Tool
- Do peptides really work?Guide
- Peptides vs GLP-1Guide
- BPC-157 vs TB-500Guide
- Semaglutide vs tirzepatideGuide
- BPC-157 vs KPVGuide
- All peptides A-ZHub
Sources
- FDA: Bulk drug substances that may present significant safety risks (Category 2 and withdrawn list)
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss
- PubMed: Aronne et al., Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5), NEJM 2025
- PubMed: Jastreboff et al., Triple-hormone-receptor agonist retatrutide for obesity, NEJM 2023
- PubMed: Poolton et al., Human evidence for BPC-157: a systematic review, 2026
- WADA: 2026 Prohibited List (official PDF)
- Drugs@FDA: approved drug database